3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Sarcoma, Endometrial Stromal
1
Perivascular Epithelioid Cell Neoplasms
1
Neoplasms by Site
1
Neoplasms
1
Central Nervous System Neoplasms
1
Central Nervous System Diseases
1
Breast Diseases
1
Brain Neoplasms
1
Brain Diseases
1
Advanced Breast Cancer
1
Adenosarcoma of the uterus
1
Interventions
Fulvestrant
19
Letrozole
8
Anastrozole
6
Capecitabine
5
palbociclib
4
olaparib
4
Paclitaxel
4
Goserelin
4
Docetaxel
4
pyrotinib
3
exemestane
3
Injections
3
toripalimab
2
sacituzumab govitecan
2
ribociclib
2
eribulin
2
elacestrant
2
abemaciclib
2
Vinorelbine
2
Trastuzumab
2
FCN-437c
2
Everolimus
2
Dasatinib
2
Aromatase Inhibitors
2
Alpelisib
2
Albumin-Bound Paclitaxel
2
AZD9833
2
vandetanib
1
trastuzumab deruxtecan
1
talazoparib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Breast Cancer
×
RAD1901
×
Clear all
NCT06382948
2026-04-03
ADELA
MedSIR
Phase 3
Recruiting
240 enrolled